Improve scientific research and innovation capabilities! Professor Jiang Wei from the Wuhan University Institute of Medical Sciences was appointed as an external expert by Beike Biotechnology

On the afternoon of September 29th, In order to promote the company to achieve high-quality development and enhance the company’s core competitiveness, Shenzhen Beike Biotechnology Co., Ltd. held a ceremony to issue external expert consultant certificates and sign a cooperation project. Dr. Hu Junyuan, chairman of Beike Biotech, and Professor Jiang Wei signed a “Letter of Intent for Cooperation Projects” and issued an external expert consultant certificate. Professor Jiang Wei is a professor at the Wuhan University School of Medicine and a distinguished researcher at Zhongnan Hospital. He has conducted in-depth research in the fields of stem cell differentiation, epigenetic regulation, and long non-coding RNA. He has published more than 30 papers in international journals and been cited by SCI more than 2,000 times.

At the signing ceremony, Beike Biotechnology and Professor Jiang Wei successfully reached a cooperation project intention. font-weight: 700; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline;”>Build a technology system for reprogramming and transdifferentiation; build a technology platform for directed differentiation of pluripotent stem cells into pancreas and islet cells; build a technology platform for directed differentiation of pluripotent stem cells into nerve cells; develop cell therapy solutions or drugs with potential for the treatment of diabetes and neurodegenerative diseases. Cooperate together in multiple fields, build a team of experts, build a team of talents, better integrate the research results of outstanding individuals or teams into the great vision of Beike Biotech, and make unremitting efforts to improve human health.

At the Central Talent Conference held in Beijing from September 27th to 29th, General Secretary Xi Jinping delivered an important speech at the meeting, emphasizes that we must adhere to facing the world’s technological frontiers, facing the main economic battlefield, facing the country’s major needs, and facing the people’s lives and health. We must deeply implement the strategy of strengthening the country through talents in the new era, cultivate, introduce and make good use of talents in an all-round way, and accelerate the construction of the world’s important talent centers and innovation highlands. This high-profile meeting draws a blueprint for talents in the new era. The signing ceremony for the talent introduction of Beike Biotech was almost synchronized with the meeting, which coincides with the national strategy and focuses on building the company’s talent team and improving the company’s strategic development layout.

As a high-tech enterprise in my country that specializes in the clinical transformation of personalized cell therapy technology, Beike Biotech’s talent is the core competitiveness of the enterprise. Especially in the rapid development stage of the enterprise, it needs the blessing of talents. At the signing ceremony, Dr. Hu Junyuan, Chairman of Beike Biotech, said that he was very happy to work with Professor Jiang Wei for a common cause. As an early enterprise in the country that entered the cell field, Beike Biotech has 16 years of valuable experience in basic cell research, clinical transformation, new drug research and development, AI intelligent big data and other fields. This cooperation is an important measure for Beike Biotech to grasp the pulse of the times, seize future trends, pool the company’s superior resources, and accelerate the establishment of corporate talent competitiveness. Next, it will continue to increase investment in scientific research and cooperate with more outstanding scientist teams. It must not only deepen technological research and development, but also undertake the important mission of transformation and promotion of results, open up the future technology engine of cutting-edge medicine, and improve people’s health.

Professor Jiang Wei said at the signing ceremony that he was very grateful to Beike Biotech for its recognition of his personal and team’s research results and its willingness to provide opportunities and platforms for the transformation of basic research results. I hope that future cooperation between the two parties can transform the scientific and technological achievements of the research team into clear industrialization goals. I am very happy to work with Beike Biotech.